Updated Cost-effectiveness Assessments of PCSK9 Inhibitors From the Perspectives of the Health System and Private Payers Insights Derived From the FOURIER Trial Article

Arrieta, Alejandro, Hong, Jonathan C., Khera, Rohan et al. (2017). Updated Cost-effectiveness Assessments of PCSK9 Inhibitors From the Perspectives of the Health System and Private Payers Insights Derived From the FOURIER Trial . JAMA CARDIOLOGY, 2(12), 1369-1374. 10.1001/jamacardio.2017.3655



Open Access

cited authors

  • Arrieta, Alejandro; Hong, Jonathan C.; Khera, Rohan; Virani, Salim S.; Krumholz, Harlan M.; Nasir, Khurram

fiu authors

publication date

  • 2017

published in

Digital Object Identifier (DOI)

start page

  • 1369

end page

  • 1374

volume

  • 2

issue

  • 12

SDG 03: Good Health and Well-being

  • true

research area